These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1199 related items for PubMed ID: 22100674

  • 21. Local drug delivery for treatment of coronary and peripheral artery disease.
    Gertz ZM, Wilensky RL.
    Cardiovasc Ther; 2011 Dec; 29(6):e54-66. PubMed ID: 20553281
    [Abstract] [Full Text] [Related]

  • 22. OrbusNeich fully absorbable coronary stent platform incorporating dual partitioned coatings.
    Cottone RJ, Thatcher GL, Parker SP, Hanks L, Kujawa DA, Rowland SM, Costa M, Schwartz RS, Onuma Y.
    EuroIntervention; 2009 Dec 15; 5 Suppl F():F65-71. PubMed ID: 22100679
    [Abstract] [Full Text] [Related]

  • 23. Current status of drug-eluting stents.
    Räber L, Windecker S.
    Cardiovasc Ther; 2011 Jun 15; 29(3):176-89. PubMed ID: 20370793
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results.
    Xu B, Dou KF, Han YL, Lü SZ, Yang YJ, Huo Y, Wang LF, Chen YD, Wang HC, Li WM, Chen JY, Wang L, Wang Y, Ge JB, Li W, Gao RL.
    Chin Med J (Engl); 2011 Mar 15; 124(6):811-6. PubMed ID: 21518585
    [Abstract] [Full Text] [Related]

  • 27. Late loss in a disappearing frame of reference: is it still applicable to fully absorbable scaffolds?
    Bangalore S, Mauri L.
    EuroIntervention; 2009 Dec 15; 5 Suppl F():F43-8. PubMed ID: 22100675
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.
    Chong E, Poh KK, Liang S, Lee RC, Low A, Teo SG, Tan HC.
    J Interv Cardiol; 2010 Apr 15; 23(2):101-8. PubMed ID: 20236214
    [Abstract] [Full Text] [Related]

  • 31. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
    Qasim A, Cosgrave J, Latib A, Colombo A.
    Am J Cardiol; 2007 Dec 01; 100(11):1619-24. PubMed ID: 18036358
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Eluting combination drugs from stents.
    Thipparaboina R, Khan W, Domb AJ.
    Int J Pharm; 2013 Sep 15; 454(1):4-10. PubMed ID: 23850234
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Stent thrombosis in the era of drug eluting stents.
    Kawaguchi R, Angiolillo DJ, Futamatsu H, Suzuki N, Bass TA, Costa MA.
    Minerva Cardioangiol; 2007 Apr 15; 55(2):199-211. PubMed ID: 17342038
    [Abstract] [Full Text] [Related]

  • 36. Rationale and design of the randomized, multicenter EREMUS trial, a study that investigates how to achieve low restenosis and early reendothelialization after percutaneous coronary interventions.
    Cortese B, Danzi GB, Pitì A, Severi S, Limbruno U.
    Catheter Cardiovasc Interv; 2011 Jul 01; 78(1):32-7. PubMed ID: 21413116
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. First nine-month complete invasive assessment (angiography, IVUS, and OCT) of the novel NEVO sirolimus-eluting stent with biodegradable polymer.
    Abizaid A, Costa JR, Feres F.
    Catheter Cardiovasc Interv; 2011 Jan 01; 77(1):49-51. PubMed ID: 20506126
    [Abstract] [Full Text] [Related]

  • 39. [Current percutaneous coronary intervention technology for management of coronary artery disease].
    Miyazawa A, Kozuma K.
    Nihon Rinsho; 2011 Feb 01; 69(2):224-9. PubMed ID: 21387667
    [Abstract] [Full Text] [Related]

  • 40. Drug-eluting versus bare-metal coronary stents: where are we now?
    Amoroso NS, Bangalore S.
    J Comp Eff Res; 2012 Nov 01; 1(6):501-8. PubMed ID: 24236469
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 60.